The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis

Starting soon · Early Phase 1

Conditions studied: Atelectases, Postoperative Pulmonary, Diabete Mellitus

In brief

Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.

Key facts

Study ID

NCT07591558

Run by

King Abdullah University Hospital

People needed

80

Starts

2026-06-01

Expected to finish

2026-12-01

Last updated by the study team

2026-05-15

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The study will include patients aged 18-70 years
• American Society of Anesthesiologists (ASA) physical status of I or II
• Will undergo thoracic, abdominal or spinal surgery

You may not qualify if…

• cardiac conditions other than hypertension like arrhythmia
• previous cardiac surgeries and valvular heart diseases

Where it is running

• King Abdullah University Hospital — Irbid, Jordan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.